Lv1
70 积分 2022-08-08 加入
mFOLFOX-HAIC+lenvatinib+PD-1 inhibitors versus GC/GS/GEMOX chemotherapy as a first line therapy for advanced biliary tract cancer: A single-center retrospective cohort study
1个月前
已关闭
Cancer survival statistics in China 2019-2021: a multicenter, population-based study
1个月前
已完结
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration
2个月前
已完结
Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer
2个月前
已完结
Comparison of hepatic arterial infusion chemotherapyversussorafenib monotherapy in patients with advanced hepatocellular carcinoma
4个月前
已完结
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
4个月前
已完结
Hepatic arterial infusion chemotherapy for cancer of the liver
4个月前
已完结
Chemotherapy in hepatocellular carcinoma
4个月前
已关闭
Exploring treatment options for biliary tract cancers: moving beyond the era of gemcitabine and platinum doublet
4个月前
已完结
Clinical complete response after trastuzumab deruxtecan 6th-line treatment for postoperative gastric cancer recurrence: a case report
5个月前
已完结
皖公网安备34019202002308
